229 related articles for article (PubMed ID: 26749795)
1. Periodontal Disease, Dental Implants, Extractions and Medications Related to Osteonecrosis of the Jaws.
Shah NP; Katsarelis H; Pazianas M; Dhariwal DK
Dent Update; 2015 Nov; 42(9):878-80, 883-4, 887-89. PubMed ID: 26749795
[TBL] [Abstract][Full Text] [Related]
2. Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review.
Nicolatou-Galitis O; Razis E; Galiti D; Galitis E; Labropoulos S; Tsimpidakis A; Sgouros J; Karampeazis A; Migliorati C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Dec; 120(6):699-706. PubMed ID: 26455289
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis and osteopenia: implications for periodontal and implant therapy.
Otomo-Corgel J
Periodontol 2000; 2012 Jun; 59(1):111-39. PubMed ID: 22507063
[TBL] [Abstract][Full Text] [Related]
4. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
Mavrokokki T; Cheng A; Stein B; Goss A
J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
[TBL] [Abstract][Full Text] [Related]
5. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
Dodson TB
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
[TBL] [Abstract][Full Text] [Related]
6. [Osteonecrosis of the jaws (ONJ) associated to antiresorptive treatment].
Larsson Wexell C; Kjellman A; Akre O
Lakartidningen; 2018 May; 115():. PubMed ID: 29809272
[TBL] [Abstract][Full Text] [Related]
7. Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.
Carmagnola D; Celestino S; Abati S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):e10-5. PubMed ID: 18801674
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment.
Otto S; Schreyer C; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum S; Pautke C
J Craniomaxillofac Surg; 2012 Jun; 40(4):303-9. PubMed ID: 21676622
[TBL] [Abstract][Full Text] [Related]
9. [Dental Implant Treatment in Patients Receiving Anti-resorptive Agents.].
Kuroshima S
Clin Calcium; 2017; 27(10):1453-1459. PubMed ID: 28947697
[TBL] [Abstract][Full Text] [Related]
10. [Bisphosphonate and osteonecrosis of the jaw.].
Taguchi A
Clin Calcium; 2017; 27(2):225-231. PubMed ID: 28123124
[TBL] [Abstract][Full Text] [Related]
11. What is the Risk of Developing Osteonecrosis Following Dental Extractions for Patients on Denosumab for Osteoporosis?
Colella A; Yu E; Sambrook P; Hughes T; Goss A
J Oral Maxillofac Surg; 2023 Feb; 81(2):232-237. PubMed ID: 36442534
[TBL] [Abstract][Full Text] [Related]
12. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
Kunchur R; Need A; Hughes T; Goss A
J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
[TBL] [Abstract][Full Text] [Related]
13. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
[TBL] [Abstract][Full Text] [Related]
15. Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw.
Goodday RH
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):527-36. PubMed ID: 26293331
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
17. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
[TBL] [Abstract][Full Text] [Related]
18. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
Shibahara T
Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis of the jaws in patients assuming bisphosphonates and sunitinib: two case reports.
Agrillo A; Nastro Siniscalchi E; Facchini A; Filiaci F; Ungari C
Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):952-7. PubMed ID: 22953645
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of Bisphosphonate-associated Osteonecrosis of the Jaw.
Fung PL; Nicoletti P; Shen Y; Porter S; Fedele S
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):537-46. PubMed ID: 26299425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
